Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study

Clinical Therapeutics

Volumn 30, Issue 8, 2008, Pages 1492-1504

  Maspero, Jorge ^a   Guerra, Frances ^b   Cuevas, Francisco ^c   Gutierrez, Jose Pablo ^d   Soto Ramos, Mario ^e   Anderton, Sally ^f   Mechali, Daniel ^g   Chan, Robert ^f   Pedersen, Søren ^h  

^a Fundacion CIDEA   (Argentina)

^b Medicina Fetal Peru Fetal Medicine Unit at Clínica Internacional and Clinica Anglo Americana   (Peru)

^c INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^d HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^e Children's Hospital of Chihuahua   (Mexico)

^f GLAXOSMITHKLINE   (United Kingdom)

^g Estrada dos Bandeirantes   (Brazil)

^h KOLDING HOSPITAL   (Denmark)

Author keywords

childhood asthma; fluticasone; salmeterol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; PLACEBO;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CONTROL; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; POWDER INHALER; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

ACETATES; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUINOLINES;

EID: 51749103126     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.07.018     Document Type: Article

References (31)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NIH publication no. 02-33659 (2007), National Institutes of Health (NIH), Bethesda, Md
2. National Asthma Education and Prevention Program: Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. NIH publication no. 08-55846 (2007), National Institutes of Health, Bethesda, Md
3. British Thoracic Society. Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 58 Suppl 1 (2003) i1-i94
4. Rabe K.F., Adachi M., Lai C.K., et al. Worldwide severity and control of asthma in children and adults: The global asthma and insights reality surveys. J Allergy Clin Immunol 114 (2004) 40-47
5. Neffen H., Fritscher C., Schacht F.C., et al., AIRLA Survey Group. Asthma control in Latin America: The Asthma Insights and Reality in Latin America (AIRLA) survey. Rev Panam Salud Publica 17 (2005) 191-197
6. Adams R.J., Fuhlbrigge A., Guilbert T., et al. Inadequate use of asthma medication in the United States: Results of the asthma in America national population survey. J Allergy Clin Immunol 110 (2002) 58-64
7. Rabe K.F., Vermeire P.A., Soriano J.B., and Maier W.C. Clinical management of asthma in 1999: The Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16 (2000) 802-807
8. Lai C.K., De Guia T.S., Kim Y.Y., et al., Asthma Insights and Reality in Asia-Pacific Steering Committee. Asthma control in the Asia-Pacific region: The Asthma Insights and Reality in Asia-Pacific Study. J Allergy Clin Immunol 111 (2003) 263-268
9. Stempel D.A., Riedel A.A., and Carranza Rosenzweig J.R. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma. Curr Med Res Opin 22 (2006) 463-470
10. Halterman J.S., Yoos H.L., Kaczorowski J.M., et al. Providers underestimate symptom severity among urban children with asthma. Arch Pediatr Adolesc Med 156 (2002) 141-146
11. Fischer G.B., and Camargos P.A. Paediatric asthma management in developing countries. Paediatr Respir Rev 3 (2002) 285-291
12. Pearce N., Aït-Khaled N., Beasley R., et al., ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 62 (2007) 758-766
13. Karadag B., Karakoc F., Ersu R., and Dagli E. Is childhood asthma still underdiagnosed and undertreated in Istanbul?. Pediatr Int. 49 (2007) 508-512
14. Barnes N.C., Jacques L., Goldfrad C., and Bateman E.D. Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg BD versus fluticasone propionate 100 microg BD alone in patients with persistent asthma: Integrated analysis of four randomised trials. Respir Med 101 (2007) 2358-2365
15. Smith G.A., Rawls C.M., and Kunka R.L. An automated method for the determination of montelukast in human plasma using dual-column HPLC analysis and peak height summation of the parent compound and its photodegradation product. Pharm Res 21 (2004) 1539-1544
16. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
17. Bateman E.D., Boushey H.A., Bousquet J., et al., GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 170 (2004) 836-844
18. Juniper E.F., Guyatt G.H., Feeny D.H., et al. Measuring quality of life in children with asthma. Qual Life Res 5 (1996) 35-46
19. Juniper E.F., Guyatt G.H., Feeny D.H., et al. Measuring quality of life in the parents of children with asthma. Qual Life Res 5 (1996) 27-34
20. Van den Berg N.J., Ossip M.S., Hederos C.A., et al. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatr Pulmonol 30 (2000) 97-105
21. De Blic J., Poterre M., Attali V., et al. Salmeterol/fluticasone propionate is superior to doubling the dose of fluticasone propionate in children with asthma. Allergy 62 Suppl 83 (2007) 397
22. Knorr B., Matz J., Bernstein J.A., et al., Pediatric Montelukast Study Group. Montelukast for chronic asthma in 6- to 14-year-old children: A randomized, double-blind trial. JAMA 279 (1998) 1181-1186
23. Lundbäck B., Rönmark E., Lindberg A., et al. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med 100 (2006) 2-10
24. Bateman E., Nelson H., Bousquet J., et al. Meta-analysis: Effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med 149 (2008) 33-42
25. Sorkness C.A., Lemanske Jr. R.F., Mauger D.T., et al., Childhood Asthma Research and Education Network of the National Heart, Lung and Blood Institute. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial [published correction appears in J Allergy Clin Immunol. 2007;120:285]. J Allergy Clin Immunol 119 (2007) 64-72
26. Garcia G.M., Wahn U., Gilles L., et al. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: The MOSAIC study. [published correction appears in Pediatrics. 2005;116:1058]. Pediatrics 116 (2005) 360-369
27. Zeiger R.S., Szefler S.J., Phillips B.R., et al., Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 117 (2006) 45-52
28. Ostrom N.K., Decotiis B.A., Lincourt W.R., et al. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr 147 (2005) 213-220
29. Carlsen K.H., and Carlsen K.C. Pharmaceutical treatment strategies for childhood asthma. Curr Opin Allergy Clin Immunol 8 (2008) 168-176
30. Peden D.B., Berger W.E., Noonan M.J., et al. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol 102 (1998) 32-38
31. Katz Y., Lebas F.X., Medley H.V., and Robson R. Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Clin Ther 20 (1998) 424-437